Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aging and the brain: a new frontier

D A Drachman1

  • 1Department of Neurology, University of Massachusetts Medical Center, Worcester 01655, USA.

Annals of Neurology
|December 24, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.

Clinical genetics·2007
Same author

Ataxia associated with Hashimoto's disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis.

Journal of neurology, neurosurgery, and psychiatry·2001
Same author

Psychological features in persons at risk for familial Alzheimer's disease.

American journal of Alzheimer's disease and other dementias·2001
Same author

Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease.

Archives of neurology·2001
Same author

Statins and the risk of dementia.

Lancet (London, England)·2000
Same author

Familial Alzheimer's disease: site of mutation influences clinical phenotype.

Annals of neurology·2000

Aging causes brain changes and increases neurological disease risk. Modifying these age-related changes (ARCs) offers a new frontier for preventing cognitive decline and extending longevity.

Area of Science:

  • Neuroscience
  • Gerontology
  • Cell Biology

Background:

  • Aging leads to senescent age-related changes (ARCs) and late-onset diseases, impacting brain function.
  • The brain's postmitotic nature makes it vulnerable to ARCs, with senescence being a major risk factor for elderly neurological diseases like Alzheimer's.
  • Understanding the biology of ARCs is shifting the view of senescence from an immutable process to a modifiable one.

Purpose of the Study:

  • To explore the biological mechanisms underlying age-related changes in the brain.
  • To investigate the link between senescence, ARCs, and neurological disease risk.
  • To identify potential targets for modifying aging processes to prevent cognitive decline.

Main Methods:

  • Review of existing literature on aging, senescence, and neurological diseases.

Related Experiment Videos

  • Analysis of factors influencing cell survival and apoptotic death.
  • Examination of models demonstrating extended longevity and their implications for ARCs.

    • Main Results:

    • Senescence is a primary risk factor for age-related neurological diseases.
    • Both programmed and variable factors contribute to ARCs and neuronal degeneration.
    • Longevity can be extended by modifying processes that produce ARCs, as shown in various models.

    Conclusions:

    • Modifying age-related changes (ARCs) is crucial for preventing increased neuronal vulnerability in senescence.
    • Understanding aging's impact on disease is the new frontier in neurology.
    • Interventions targeting ARCs hold promise for preventing cognitive decline and extending healthy lifespan.